{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:03:06Z","timestamp":1791295386772,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T00:00:00Z","timestamp":1387756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083006","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T22:10:22Z","timestamp":1387836622000},"page":"e83006","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance"],"prefix":"10.1371","volume":"8","author":[{"given":"Courtney M.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Kurbatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor S.","family":"Click","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Sean","family":"Cavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Cegielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/425005","article-title":"The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis","volume":"39","author":"KJ Seung","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref2","first-page":"74","article-title":"Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India","volume":"13","author":"M Hanif","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/592252","article-title":"Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda","volume":"47","author":"B Temple","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref4","first-page":"10","article-title":"How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis","volume":"2","author":"DA Mitchison","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref5","first-page":"672","article-title":"Management of drug-resistant tuberculosis","volume":"14","author":"CY Chiang","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","unstructured":"World Health Organization (2008) Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Geneva: World Health Organization, Stop TB Department."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1128\/JCM.43.7.3530-3532.2005","article-title":"Does resistance to pyrazinamide accurately indicate the presence of Mycobacterium bovis?","volume":"43","author":"BC de Jong","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"S Gagneux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3201\/eid0805.020002","article-title":"Worldwide occurrence of Beijing\/W strains of Mycobacterium tuberculosis: a systematic review","volume":"8","author":"JR Glynn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3201\/eid1205.050400","article-title":"Beijing\/W genotype Mycobacterium tuberculosis and drug resistance","volume":"12","author":"Markers European Concerted Action on New Generation Genetic","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1128\/JCM.01812-08","article-title":"Predominance of Mycobacterium tuberculosis EAI and Beijing lineages in Yangon, Myanmar","volume":"47","author":"S Phyu","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e52297","DOI":"10.1371\/journal.pone.0052297","article-title":"First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Nepal","volume":"7","author":"B Malla","year":"2012","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/AAC.06460-11","article-title":"Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis","volume":"56","author":"L Fenner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cid\/cir788","article-title":"Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis","volume":"54","author":"ES Click","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref15","first-page":"131","article-title":"Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes","volume":"15","author":"M Kato-Maeda","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1073\/pnas.0511240103","article-title":"Variable host-pathogen compatibility in Mycobacterium tuberculosis","volume":"103","author":"S Gagneux","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","first-page":"1","article-title":"Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America","volume":"52","year":"2003","journal-title":"MMWR"},{"key":"ref18","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"DA Mitchison","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref19","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Y Zhang","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1099\/0022-1317-51-1-42","article-title":"Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide","volume":"51","author":"Y Zhang","year":"2002","journal-title":"J Med Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/JCM.01775-09","article-title":"Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide","volume":"48","author":"P Chedore","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","author":"DA Duong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3201\/eid1804.110912","article-title":"Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB","volume":"18","author":"JE de Steenwinkel","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ng.2656","article-title":"Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis","volume":"45","author":"CB Ford","year":"2013","journal-title":"Nat Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-149-2-200807150-00008","article-title":"Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis","volume":"149","author":"W Lew","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lee SS, Meintjes G, Kamarulzaman A, Leung CC (2013) Management of tuberculosis and latent tuberculosis infection in HIV-infected persons. Respirology.","DOI":"10.1111\/resp.12120"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(98)11467-8","article-title":"Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium","volume":"353","author":"A Vernon","year":"1999","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1086\/430377","article-title":"Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997\u20132000","volume":"41","author":"J Li","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref29","unstructured":"CDC (2012) Reported Tuberculosis in the United States, 2011. Atlanta, GA: Department of Health and Human Services, CDC."},{"key":"ref30","unstructured":"World Health Organization (2006) Global Plan to Stop TB 2006\u20132015. Geneva: World Health Organization."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/cit167","article-title":"A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients","volume":"57","author":"JG Pasipanodya","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/cid\/cis748","article-title":"Acquired resistance to second-line drugs among persons with tuberculosis in the United States","volume":"55","author":"JV Ershova","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/infdis\/jit352","article-title":"Serum drug concentrations predictive of pulmonary tuberculosis outcomes","volume":"208","author":"JG Pasipanodya","year":"2013","journal-title":"J Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/CMR.00021-12","article-title":"Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control","volume":"25","author":"T Cohen","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200408-1081OC","article-title":"Recurrent tuberculosis in the United States and Canada: relapse or reinfection?","volume":"170","author":"RM Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/589240","article-title":"Human tuberculosis due to Mycobacterium bovis in the United States, 1995\u20132005","volume":"47","author":"MC Hlavsa","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref37","unstructured":"World Health Organization (2006) Global tuberculosis control: WHO report. Geneva: Global Tuberculosis Programme."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T08:53:30Z","timestamp":1564995210000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083006"}},"subtitle":[],"editor":[{"given":"Madhukar","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,23]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083006","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,23]]}}}